Cargando…

Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study

BACKGROUND: Tuberculosis (TB) is still the most common infectious disease globally, affecting 1.5 million people per year. Prior to COVID-19 outbreak, India was struggling with a rampant attack of Tuberculosis. With the surge of COVID-19 implementation of all national health programs including NTEP...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabbur, Satish, Patil, Bhagyashree, Angolkar, Mubashir, Narasannavar, Ashwini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463076/
https://www.ncbi.nlm.nih.gov/pubmed/37562908
http://dx.doi.org/10.1016/j.ijtb.2022.09.001
_version_ 1784787328757137408
author Kabbur, Satish
Patil, Bhagyashree
Angolkar, Mubashir
Narasannavar, Ashwini
author_facet Kabbur, Satish
Patil, Bhagyashree
Angolkar, Mubashir
Narasannavar, Ashwini
author_sort Kabbur, Satish
collection PubMed
description BACKGROUND: Tuberculosis (TB) is still the most common infectious disease globally, affecting 1.5 million people per year. Prior to COVID-19 outbreak, India was struggling with a rampant attack of Tuberculosis. With the surge of COVID-19 implementation of all national health programs including NTEP was disrupted. Prioritization of services, the challenges to reaching all types of communities and the role of stigmatization, and the possibility of increased disease transmission were few problems in the implementation of DOTS during the lockdown. AIM: To assess effect of pandemic on DOTS treatment during COVID-19 lockdown. METHODS: A cross-sectional study was conducted among 254 tuberculosis patients who were under DOTS during Covid-19 lockdown in Belagavi district. Participants who were on DOTS during 2019–2021 period. RESULT: Of 254 participants, only 5 (2.0%) were supervised while taking drugs, 67 (26.4%) of subject's empty blister packs were taken back by health personnel and 106 (41.7%) participants were regularly followed up for treatment by health department. The variables like gender, literacy status, socioeconomic status, and occupation were all significantly associated with hampered access to DOTS during the lockdown period at p < 0.05. CONCLUSION: This study concluded that the participants had hampered accessibilities to DOTS during lockdown.
format Online
Article
Text
id pubmed-9463076
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tuberculosis Association of India. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94630762022-09-10 Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study Kabbur, Satish Patil, Bhagyashree Angolkar, Mubashir Narasannavar, Ashwini Indian J Tuberc Original Article BACKGROUND: Tuberculosis (TB) is still the most common infectious disease globally, affecting 1.5 million people per year. Prior to COVID-19 outbreak, India was struggling with a rampant attack of Tuberculosis. With the surge of COVID-19 implementation of all national health programs including NTEP was disrupted. Prioritization of services, the challenges to reaching all types of communities and the role of stigmatization, and the possibility of increased disease transmission were few problems in the implementation of DOTS during the lockdown. AIM: To assess effect of pandemic on DOTS treatment during COVID-19 lockdown. METHODS: A cross-sectional study was conducted among 254 tuberculosis patients who were under DOTS during Covid-19 lockdown in Belagavi district. Participants who were on DOTS during 2019–2021 period. RESULT: Of 254 participants, only 5 (2.0%) were supervised while taking drugs, 67 (26.4%) of subject's empty blister packs were taken back by health personnel and 106 (41.7%) participants were regularly followed up for treatment by health department. The variables like gender, literacy status, socioeconomic status, and occupation were all significantly associated with hampered access to DOTS during the lockdown period at p < 0.05. CONCLUSION: This study concluded that the participants had hampered accessibilities to DOTS during lockdown. Tuberculosis Association of India. Published by Elsevier B.V. 2022-09-10 /pmc/articles/PMC9463076/ /pubmed/37562908 http://dx.doi.org/10.1016/j.ijtb.2022.09.001 Text en © 2022 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Kabbur, Satish
Patil, Bhagyashree
Angolkar, Mubashir
Narasannavar, Ashwini
Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study
title Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study
title_full Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study
title_fullStr Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study
title_full_unstemmed Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study
title_short Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study
title_sort effect of pandemic on dots treatment during covid-19 lockdown- a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463076/
https://www.ncbi.nlm.nih.gov/pubmed/37562908
http://dx.doi.org/10.1016/j.ijtb.2022.09.001
work_keys_str_mv AT kabbursatish effectofpandemicondotstreatmentduringcovid19lockdownacrosssectionalstudy
AT patilbhagyashree effectofpandemicondotstreatmentduringcovid19lockdownacrosssectionalstudy
AT angolkarmubashir effectofpandemicondotstreatmentduringcovid19lockdownacrosssectionalstudy
AT narasannavarashwini effectofpandemicondotstreatmentduringcovid19lockdownacrosssectionalstudy